Effects of a nitric oxide synthase inhibitor in humans with septic shock
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Studies in animals have indicated that increased production of nitric oxide from an inducible isoform of nitric oxide synthase contributes to the pathophysiology of endotoxic and cytokine induced shock. The aim of this study was to determine the role of nitric oxide in septic shock in humans. METHODS: The study was a randomised, double blind, placebo controlled investigation of the effects of the nitric oxide synthase inhibitor NG monomethyl-L-arginine (L-NMMA) in 12 patients with severe sepsis associated with hypotension. Measurements of haemodynamic, haematological, and biochemical variables were made. RESULTS: L-NMMA (0.3 and 1 mg.kg-1) produced a dose dependent increase in mean arterial pressure, systemic vascular resistance, pulmonary vascular resistance, central venous pressure, and pulmonary artery occlusion pressure, and a decrease in cardiac output and heart rate. In response to the highest dose of L-NMMA systemic vascular resistance increased from 547(SEM 92) to 889(143) dyne.s.cm-5, mean arterial blood pressure increased from 80.9(2.9) to 100.5(6.1) mm Hg, and cardiac output decreased from 11.2(2.1) to 8.9(1.9) litres.min-1. Continuous infusion of L-NMMA (1 mg.kg-1 x h-1) produced sustained haemodynamic changes. Platelet numbers decreased during the course of the study in both the L-NMMA and the placebo group and did not differ significantly between the groups. CONCLUSIONS: Low doses of L-NMMA cause a widespread increase in vascular tone and raise blood pressure in patients with septic shock. Overproduction of nitric oxide appears to be an important mechanism in septic shock in patients, and inhibition of nitric oxide synthesis might provide a novel therapeutic approach to this condition. However, L-NMMA produced a fall in cardiac output and it is possible that this would worsen tissue perfusion. Larger studies examining the effects of L-NMMA on mortality and morbidity are now required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
Fang, F. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1004 · Cited by 1,676
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Briegel, J., Forst, H., Haller, M., Schelling, G., Kilger, E., Kuprat, G., Hemmer, B., Hummel, T., Lenhart, A., Heyduck, M., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199904000-00025 · Cited by 889
Mechanisms of sepsis-induced cardiac dysfunction
Rudiger, A., & Singer, M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000266683.64081.02 · Cited by 704
INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
Hobbs, A. J., Higgs, A., & Moncada, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.191 · Cited by 596
Self-citationStrategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
Self-citationIntensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Biological significance of endogenous methylarginines that inhibit nitric oxide synthases
Leiper, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00162-5 · Cited by 458
Titheradge, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00031-6 · Cited by 457
Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
(1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00049 · Cited by 438
Effects of Nitric Oxide in Septic Shock
VINCENT, J.-L., ZHANG, H., SZABO, C., & PREISER, J.-C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9812004 · Cited by 351
Nitric oxide and intestinal inflammation
Kubes, P., & McCafferty, D.-M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00480-0 · Cited by 347
Blocking NO synthesis: how, where and why?
Vallance, P., & Leiper, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd960 · Cited by 331
Self-citationReactive Nitrogen Species: Molecular Mechanisms and Potential Significance in Health and Disease
Martínez, M. C., & Andriantsitohaina, R. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1993 · Cited by 324
Garvey, E. P., Oplinger, J. A., Tanoury, G. J., Sherman, P. A., Fowler, M., Marshall, S., Harmon, M. F., Paith, J. E., & Furfine, E. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47071-8 · Cited by 315
Darley-Usmar, V., & Halliwell, B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016079012214 · Cited by 313
Thiemermann, C. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00410-7 · Cited by 303
Sepsis: Inflammation Is a Necessary Evil
Nedeva, C., Menassa, J., & Puthalakath, H. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00108 · Cited by 301
Endothelial dysfunction: Clinical implications
DREXLER, H. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80030-8 · Cited by 293
Effect of high-dose Ascorbic acid on vasopressor′s requirement in septic shock
Khalili, H., Zabet, M., Mohammadi, M., & Ramezani, M. (2016) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.179569 · Cited by 287
Reversible Binding and Inhibition of Catalase by Nitric Oxide
Brown, G. C. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20798.x · Cited by 278
Methylene blue administration in septic shock: A clinical trial
Preiser, J.-C., Lejeune, P., Roman, A., Carlier, E., De Backer, D., Leeman, M., Kahn, R. J., & Vincent, J.-L. (1995) · Critical Care Medicine · doi:10.1097/00003246-199502000-00010 · Cited by 263
The Emerging Multifaceted Roles of Nitric Oxide
Kuo, P. C., & Schroeder, R. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199503000-00003 · Cited by 262
Nitric oxide in inflammation and immune response
Moilanen, E., & Vapaatalo, H. (1995) · Annals of Medicine · doi:10.3109/07853899509002589 · Cited by 242
Inducible nitric oxide synthase: Good or bad?
Lind, M., Hayes, A., Caprnda, M., Petrovic, D., Rodrigo, L., Kruzliak, P., & Zulli, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.036 · Cited by 229
The Effects of Intravenous Antioxidants in Patients With Septic Shock
Galley, H. F., Howdle, P. D., Walker, B. E., & Webster, N. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00059-2 · Cited by 203
Is nitric oxide overproduction the target of choice for the management of septic shock?
Feihl, F., Waeber, B., & Liaudet, L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00155-3 · Cited by 151
Nakayama, T., & Oishi, K. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12142 · Cited by 97
Evidence that nitric oxide mechanisms regulate small intestinal motility in humans
Russo, A., Fraser, R., Adachi, K., Horowitz, M., & Boeckxstaens, G. (1999) · Gut · doi:10.1136/gut.44.1.72 · Cited by 92
Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse
Rees, D. D., Monkhouse, J. E., Cambridge, D., & Moncada, S. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701815 · Cited by 86
“This L-NMMA-induced increase in blood pressure, which has also been observed in man (Petros et al., 1991; 1994), may be important for the successful management of septic shock.”
BackgroundSelf-citationPlasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease
Dykhuizen, R. S., Masson, J., McKnight, G., Mowat, A. N., Smith, C. C., Smith, L. M., & Benjamin, N. (1996) · Gut · doi:10.1136/gut.39.3.393 · Cited by 59
sGCα1β1attenuates cardiac dysfunction and mortality in murine inflammatory shock models
Buys, E. S., Cauwels, A., Raher, M. J., Passeri, J. J., Hobai, I., Cawley, S. M., Rauwerdink, K. M., Thibault, H., Sips, P. Y., Thoonen, R., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2009 · Cited by 49
Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Suzuki, T., Ueda, Y., Yamada, S., Shoji, H., Takeuchi, M., Ueda, S., et al. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.05.002 · Cited by 46
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2
Citterio, G., Pellegatta, F., Lucca, G., Fragasso, G., Scaglietti, U., Pini, D., Fortis, C., Tresoldi, M., & Rugarli, C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.533 · Cited by 18
Metadata
- Authors
- Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., & Vallance, P.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-01-01
- Volume
- 28
- Issue
- 1
- Pages
- 34-39
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2029583951
- Cited by
- 509
- References
- 0
- FWCI
- 46.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.